Amedeo Nuzzo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?
Journal: Expert review of anticancer therapy
Published: June 10, 2026
How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 14, 2026
177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.
Journal: Expert review of anticancer therapy
Published: May 06, 2026
Lorlatinib atypical safety profile in ALK-positive aNSCLC: tips for management from an Italian expert panel.
Journal: Future oncology (London, England)
Published: January 14, 2026
An update on the treatment paradigm for non-clear cell renal cell carcinoma.
Journal: Expert review of clinical pharmacology
Published: January 10, 2026
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib.
Journal: JCO precision oncology
Published: August 18, 2025
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma.
Journal: Frontiers in molecular biosciences
Published: September 04, 2023
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study.
Journal: Frontiers in oncology
Published: April 11, 2022
Last Updated: 09/26/2026